AABB 2005 Industry Workshops

The following workshops were presented at the AABB Annual Meeting and TXPO 2005, October 15-18, 2005, Seattle, Washington. Click on the links below to open the presentations. (Presentations and full audio are included, and may take a few minutes to download.)

Operating Efficiency and Workflow Benefits of Pall Optimized Leukoreduction Systems

Operations staff share how their respective facilities – blood centers and hospitals – have implemented Leukotrap® WB and SAVE System and the Leukotrap RC System with the RC2D Filter. Learn how optimized leukoreduction has made a successful difference to blood center operations using real-case experience. Improving cGMP compliance, reducing expenses, maximizing resources and improving blood inventory are some of the topics covered by this special workshop.

	Opening Comments: Pall Components and Systems Overview Brenda J. Pina, Portfolio Manager, Pall Medical Overview of system benefits and components for the Pall Sample Diversion Pouch Sampling System, Leukotrap RC System with RC2D Filter, and Leukotrap WB with Pall SAVE System.
	Case Study 1: Collections Experience with the Leukotrap WB with SAVE System Andrew Fry, Satellite Center Manager, United Blood Services, Farmington, New Mexico Hear about the improved donation experience for both collections staff and donors with the Pall Sample Diversion Pouch Sampling System.
	Case Study 2: Leukotrap RC Filtration System with the RC2D Filter Lisa S. Fults, BS, MT(ASCP), Assistant Director of Product Management, South Texas Blood & Tissue Center, San Antonio, Texas Hear how the transition from a dockable filtration system to the Leukotrap RC System with In-line RC2D Filter streamlined processing and reduced processing errors.

	Case Study 3: Whole Blood Collection Using the Pall System in Pediatrics Deborah Noonan, MBA, The Children’s Hospital, Denver, Colorado Learn how a hospital-based collection center improved processing at both their fixed and mobile sites with the Leukotrap WB with SAVE System.
	Case Study 4: Whole Blood Filtration with the Pall Leukotrap® WB System with In-line WBF2 Filter Elizabeth Escobar, BS, MT(ASCP), Technical Services Director, United Blood Services, El Paso, Texas Describes how the transition from a dockable filtration system to the Leukotrap WB with SAVE System allowed this center to increase whole blood collections and still decrease processing time.
	Case Study 5: Use of the Leukotrap® WB with the Pall SAVE System in Our Facility Laura Starkey, MT(ASCP), SBB, Laboratory Services Manufacturing Manager, Central Ohio Region, Columbus, Ohio Hear about the ergonomic improvements realized when this center compared a bypass whole blood filtration system to the Leukotrap WB with SAVE System.

Acrodose™ PL System, The New Platform for Platelet Transfusion Safety

Learn how pre-storage pooling with the Pall Acrodose PL System completes the platform for leukoreduction of whole blood-derived platelets. Our distinguished speakers discuss the evolving status of whole blood-derived platelets from their own experiences, including:

The operational and transfusion safety benefits of an Acrodose Platelet.
How an Acrodose Platelet is a value-added product for hospital customers that can boost platelet supply through whole blood donations.
Data from recent in vivo studies of whole blood-derived platelets and in vitro studies of the Pall Acrodose PL System.
Improved economics and sensitivity of bacteria culture testing of a pooled platelet product.
How hospital handling costs are lowered by eliminating the need for pooling and bacteria testing.

Applicability of the Acrodose™ PL System for a Community Blood Center and Its Customers
Susan Wilkinson, EdD, Associate Director and Associate Professor, Hoxworth Blood Center, University of Cincinnati Medical Center, Cincinnati, Ohio
Hear about the operational, safety, and cost benefits of implementing the Acrodose PL System from the blood center perspective.

Improvements in the Preparation of Platelets from Whole Blood for Transfusion
Ralph R. Vassallo, MD, Senior Medical Director, American Red Cross Blood Services, Penn-Jersey Region
Learn about quality and clinical benefits of a whole blood platelet, and review the validation studies that have been performed with the Acrodose PL System. Key points covered include in-vivo and in-vitro studies, as well as increased platelet availability from whole blood platelets.

Pre-pooled Platelet Concentrates, A Hospital Transfusion Perspective
Laura Cooling, MD, MS, Assistant Professor, Department of Pathology, Associate Medical Director, Transfusion Medicine, University of Michigan, Ann Arbor, Michigan
Focuses on the hospital's perspective on the current status of whole blood platelets and the benefits that a culture-tested, pooled platelet product can bring to both the hospital and patient. Key points include increased sensitivity from culture-based bacteria detection, increased platelet availability, and cost savings to the hospital.

Closing Comments: The Pall Acrodose™ PL System
Robert Haime, Sr. Director Portfolio Management, Whole Blood Platelet Program, Pall Medical
Introduces Pall's Acrodose PL System for whole blood platelet pooling and covers system features, benefits, etc. Learn how Pall offers a complete system for safer whole blood platelets, from whole blood collection to bacteria detection, and how the Acrodose PL System completes the platform for platelet transfusion safety.